Trial intelligence / Profile preview

NPH insulin versus sliding scale insulin for glucocorticoid-induced hyperglycemia during chemotherapy

NL-OMON41445Active, not recruiting

Sponsor
Slotervaartziekenhuis
Start
Jun 2014
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Randomised, open-label trial of insulin isophane and insulin aspart in corticosteroid-induced hyperglycemia (GIH) (2 arms), sponsored by Slotervaartziekenhuis. Started Jun 2014; status: active, not recruiting.

02

Drugs

insulin isophaneinsulin aspart
03

Conditions

corticosteroid-induced hyperglycemia (GIH)

Beyond the preview

Go deeper on NL-OMON41445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call